SCHEMBL1665239

SCHEMBL1665239

CCn1c(C)ccc1C(=O)Nc1ccc(Nc2ccc(Nc3ccc(N4CCC(O)CC4)cc3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.46
HPGDS O60760 1/20 0.44
NPC1 O15118 9/20 0.43
RAB9A P51151 9/20 0.43
PDE7A Q13946 1/20 0.42
MAPT P10636 4/20 0.41
KMT2A Q03164 2/20 0.41
MCL1 Q07820 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 2/20 0.40
USP2 O75604 1/20 0.40
AXL P30530 1/20 0.40
FLT3 P36888 1/20 0.40
TYRO3 Q06418 1/20 0.40
MERTK Q12866 1/20 0.40
GAS6 Q14393 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1665243 0.96 MAPT (0.48) SMN1; SMN2NPC1RAB9AMAPTKMT2A
SCHEMBL1665072 0.85 HPGDS (0.48) SMN1; SMN2HPGDSNPC1RAB9APDE7A
SCHEMBL1665074 0.82 RAB9A (0.52) SMN1; SMN2HPGDSNPC1RAB9AMAPT
SCHEMBL1664088 0.80 HPGDS (0.53) SMN1; SMN2HPGDSNPC1RAB9AMAPT
SCHEMBL21254734 0.79 KDM1A (0.39) SMN1; SMN2NPC1RAB9AMAPTKMT2A
SCHEMBL1664638 0.78 EGFR (0.44) SMN1; SMN2HPGDSNPC1RAB9APDE7A
SCHEMBL1663443 0.77 KMT2A (0.46) SMN1; SMN2NPC1RAB9AMAPTKMT2A
SCHEMBL8769706 0.77 RAB9A (0.58) SMN1; SMN2NPC1RAB9AMAPTKMT2A
SCHEMBL1664091 0.77 HPGDS (0.50) SMN1; SMN2HPGDSNPC1RAB9AMAPT
SCHEMBL1663915 0.77 PDE7A (0.42) SMN1; SMN2HPGDSNPC1RAB9APDE7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed